HMGCS2 gain-of-function in AECII lipid metabolism regulation

Exploratory Score: 0.900 Price: $0.50 idiopathic pulmonary fibrosis human AECIIs Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting HMGCS2 in human AECIIs. Primary outcome: lipid metabolism restoration

Description

Gain-of-function experiments were performed to study the role of 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) in regulating alveolar epithelial cell lipid metabolism. Ectopic expression of HMGCS2 in AECIIs was achieved to investigate its effects on lipid degradation and cellular function. The experiments demonstrated that HMGCS2 promotes lipid degradation through interaction with PPARα and upregulation of CPT1A and CPT2 expression.

TARGET GENE
HMGCS2
MODEL SYSTEM
human AECIIs
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
lipid metabolism, fatty acid oxidation, PPARα signaling
SOURCE
extracted_from_pmid_38658970
PRIMARY OUTCOME
lipid metabolism restoration

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

CPT2geneExperimentsindex

Protocol

Overexpression of HMGCS2, assessment of lipid degradation markers and CPT1A/CPT2 expression

Expected Outcomes

Enhanced lipid degradation and improved AECII function

Success Criteria

Increased CPT1A/CPT2 expression and reduced lipid accumulation

Related Hypotheses (4)

Ketone Utilization Index as Metabolic Flexibility Biomarker0.664
Biphasic Ketogenic Intervention Protocol0.654
Temporal Metabolic Window Therapy0.506
The Glial Ketone Metabolic Shunt Hypothesis0.398

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.